US STOCK
MRNA Stock Analysis
US stocks · market data · technical indicators
Moderna, Inc.
MRNAUS stocksQuote delayed 15 min
10/26 下午03:37 updated
$200.10
-2.53-1.25%
Open
$196.69
High
$206.97
Low
$183.00
Volume
2,158.62萬
MRNA price history
+1.43%Open
197.28
Latest
200.10
High
245.81
Low
187.46
Average
210.49
Advertisement
Financial snapshot
MRNA - Moderna, Inc.
EPS
-7.98USD
Forward EPS
-4.57USD
P/E
--
Forward P/E
-43.80x
P/B
11.81x
ROE
-39.00%
ROA
-13.26%
Operating margin
-557.93%
Profit margin
-141.43%
Revenue growth
2.10%
Earnings growth
--
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $143.00M | $389.00M | $676.00M | $1.00B | $137.00M |
| Gross profit | $50.00M | -$566.00M | $224.00M | $795.00M | $18.00M |
| Operating income | -$815.00M | -$1.39B | -$857.00M | -$260.00M | -$907.00M |
| Net income | -$782.00M | -$1.34B | -$826.00M | -$200.00M | -$825.00M |
| Basic EPS | -1.97 | -3.40 | -2.11 | -0.51 | -2.13 |
| Diluted EPS | -1.97 | -3.40 | -2.11 | -0.51 | -2.13 |
Estimates vs actuals
Next earnings
2026-11-06
EPS estimate
-1.35
Revenue estimate
$891.31M
Last surprise
+4.33%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-06 | -1.28 | Not reported | — |
| 2026-07-31 | -2.06 | -1.97 | +4.33% |
| 2026-04-30 | -3.88 | -3.40 | +12.37% |
| 2026-02-13 | -2.64 | -2.11 | +20.18% |
| 2025-11-06 | -2.16 | -0.51 | +76.42% |
| 2025-08-01 | -3.00 | -2.13 | +28.96% |
| 2025-05-01 | -3.11 | -2.52 | +18.89% |
| 2025-02-14 | -2.73 | -2.91 | -6.65% |
| 2024-11-07 | -1.94 | 0.03 | +101.55% |
| 2024-08-01 | -3.35 | -3.33 | +0.65% |
| 2024-05-02 | -3.57 | -3.07 | +14.06% |
| 2024-02-22 | -0.99 | 0.55 | +155.57% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $3B | 0.07% |
| VANGUARD GROUP INC | 2025-12-31 | $1.2B | 0.02% |
| STATE STREET CORP | 2026-06-30 | $1.1B | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $503.8M | 0.36% |
| CITADEL ADVISORS LLC | 2026-06-30 | $20.6M | 0.00% |
| Bridgewater Associates, LP | 2026-06-30 | $807.2K | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$138.37
Target range
$45.00 – $251.00
Implied upside
-30.85%
Strong buy
1
Buy
4
Hold
14
Sell
2
Strong sell
2
Advertisement